These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 26260289

  • 1. A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer.
    Samardzija C, Luwor RB, Volchek M, Quinn MA, Findlay JK, Ahmed N.
    Mol Cancer; 2015 Aug 11; 14():152. PubMed ID: 26260289
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer.
    Chen L, Yao Y, Sun L, Zhou J, Miao M, Luo S, Deng G, Li J, Wang J, Tang J.
    Cell Physiol Biochem; 2017 Aug 11; 43(6):2489-2504. PubMed ID: 29131012
    [Abstract] [Full Text] [Related]

  • 6. ZEB2 facilitates peritoneal metastasis by regulating the invasiveness and tumorigenesis of cancer stem-like cells in high-grade serous ovarian cancers.
    Li Y, Fei H, Lin Q, Liang F, You Y, Li M, Wu M, Qu Y, Li P, Yuan Y, Chen T, Jiang H.
    Oncogene; 2021 Aug 11; 40(32):5131-5141. PubMed ID: 34211089
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. ABCC4/MRP4 contributes to the aggressiveness of Myc-associated epithelial ovarian cancer.
    Jung M, Gao J, Cheung L, Bongers A, Somers K, Clifton M, Ramsay EE, Russell AJ, Valli E, Gifford AJ, George J, Kennedy CJ, Wakefield MJ, Topp M, Ho GY, Australian Ovarian Cancer StudyPeter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Scott CL, Bowtell DD, deFazio A, Norris MD, Haber M, Henderson MJ.
    Int J Cancer; 2020 Oct 15; 147(8):2225-2238. PubMed ID: 32277480
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. S100A7 Regulates Ovarian Cancer Cell Metastasis and Chemoresistance Through MAPK Signaling and Is Targeted by miR-330-5p.
    Lin M, Xia B, Qin L, Chen H, Lou G.
    DNA Cell Biol; 2018 May 15; 37(5):491-500. PubMed ID: 29485916
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer.
    Mercier PL, Bachvarova M, Plante M, Gregoire J, Renaud MC, Ghani K, Têtu B, Bairati I, Bachvarov D.
    Mol Oncol; 2011 Oct 15; 5(5):438-53. PubMed ID: 21856257
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer.
    Harrington BS, He Y, Davies CM, Wallace SJ, Adams MN, Beaven EA, Roche DK, Kennedy C, Chetty NP, Crandon AJ, Flatley C, Oliveira NB, Shannon CM, deFazio A, Tinker AV, Gilks CB, Gabrielli B, Brennan DJ, Coward JI, Armes JE, Perrin LC, Hooper JD.
    Br J Cancer; 2016 Feb 16; 114(4):417-26. PubMed ID: 26882065
    [Abstract] [Full Text] [Related]

  • 16. Microparticles from ovarian carcinomas are shed into ascites and promote cell migration.
    Press JZ, Reyes M, Pitteri SJ, Pennil C, Garcia R, Goff BA, Hanash SM, Swisher EM.
    Int J Gynecol Cancer; 2012 May 16; 22(4):546-52. PubMed ID: 22315094
    [Abstract] [Full Text] [Related]

  • 17. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
    Lee YJ, Wu CC, Li JW, Ou CC, Hsu SC, Tseng HH, Kao MC, Liu JY.
    Oncotarget; 2016 Nov 29; 7(48):78499-78515. PubMed ID: 27655682
    [Abstract] [Full Text] [Related]

  • 18. Chondroitin Sulfate Proteoglycan 4 Provides New Treatment Approach to Preventing Peritoneal Dissemination in Ovarian Cancer.
    Uno K, Koya Y, Yoshihara M, Iyoshi S, Kitami K, Sugiyama M, Miyamoto E, Mogi K, Fujimoto H, Yamakita Y, Wang X, Nawa A, Kajiyama H.
    Int J Mol Sci; 2024 Jan 28; 25(3):. PubMed ID: 38338902
    [Abstract] [Full Text] [Related]

  • 19. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
    Zeng S, Liu S, Feng J, Gao J, Xue F.
    Cancer Biomark; 2019 Jan 28; 24(4):421-428. PubMed ID: 30909184
    [Abstract] [Full Text] [Related]

  • 20. FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells.
    Choi EJ, Seo EJ, Kim DK, Lee SI, Kwon YW, Jang IH, Kim KH, Suh DS, Kim JH.
    Oncotarget; 2016 Jan 19; 7(3):3506-19. PubMed ID: 26654944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.